Details

Autor(en) / Beteiligte

• Ren, Ding
• Zhu, Xiaoping
• Kong, Ren
• Zhao, Zhen
• Sheng, Jianting
• Wang, Jiang
• Xu, Xiaoyun
• Liu, Jiyong
• Cui, Kemi
• Zhang, Xiang H-F
• Zhao, Hong
• Wong, Stephen T C

Titel

Targeting Brain-Adaptive Cancer Stem Cells Prohibits Brain Metastatic Colonization of Triple-Negative Breast Cancer

Ist Teil von

• Cancer research (Chicago, Ill.), 2018-04, Vol.78 (8), p.2052-2064

Ort / Verlag

United States: American Association for Cancer Research, Inc

Erscheinungsjahr

2018

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Triple-negative breast cancer (TNBC) exhibits more traits possessed by cancer stem cells (CSC) than other breast cancer subtypes and is more likely to develop brain metastases. TNBC patients usually have shorter survival time after diagnosis of brain metastasis, suggesting an innate ability of TNBC tumor cells in adapting to the brain. In this study, we establish novel animal models to investigate early tumor adaptation in brain metastases by introducing both patient-derived and cell line-derived CSC-enriched brain metastasis tumorsphere cells into mice. We discovered astrocyte-involved tumor activation of protocadherin 7 (PCDH7)-PLCβ-Ca2+-CaMKII/S100A4 signaling as a mediator of brain metastatic tumor outgrowth. We further identified and evaluated the efficacy of a known drug, the selective PLC inhibitor edelfosine, in suppressing the PCDH7 signaling pathway to prohibit brain metastases in the animal models. The results of this study reveal a novel signaling pathway for brain metastases in TNBC and indicate a promising strategy of metastatic breast cancer prevention and treatment by targeting organ-adaptive cancer stem cells. These findings identify a compound to block adaptive signaling between cancer stem cells and brain astrocytes. .